Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1354744-91-4
2. Nktr-118 Oxalate
3. Naloxegol (oxalate)
4. Naloxegol Oxalate [usan]
5. Az13337019 Oxalate
6. Az-13337019 Oxalate
7. 65i14tnm33
8. Moventig
9. (4r,4as,7s,7ar,12bs)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic Acid
10. Naloxegol Oxalate (usan)
11. Unii-65i14tnm33
12. Movantik (tn)
13. Moventig (tn)
14. Nktr-118-oxalate
15. Naloxegol Oxalate [mi]
16. Naloxegol Oxalate(nktr-118)
17. Chembl2219416
18. Schembl20839999
19. Hy-a0118a
20. Dtxsid50159395
21. Naloxegol Oxalate [who-dd]
22. Akos030526444
23. Cs-5349
24. Naloxegol Oxalate [orange Book]
25. Nktr-118;az-13337019 Oxalate
26. Ac-36031
27. Movantik Component Naloxegol Oxalate
28. Az 13337019
29. Naloxegol Oxalate Component Of Movantik
30. D10375
31. Q27263878
32. 4,5.alpha.-epoxy-6.alpha.-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate
33. 4,5alpha-epoxy-6alpha-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate
34. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5.alpha.,6.alpha.)-, Ethanedioate (1:1)
35. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5alpha,6alpha)-, Ethanedioate (1:1)
Molecular Weight | 741.8 g/mol |
---|---|
Molecular Formula | C36H55NO15 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 25 |
Exact Mass | 741.35717005 g/mol |
Monoisotopic Mass | 741.35717005 g/mol |
Topological Polar Surface Area | 201 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 971 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).
A06AH03
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Naloxegol Oxalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naloxegol Oxalate, including repackagers and relabelers. The FDA regulates Naloxegol Oxalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naloxegol Oxalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naloxegol Oxalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naloxegol Oxalate supplier is an individual or a company that provides Naloxegol Oxalate active pharmaceutical ingredient (API) or Naloxegol Oxalate finished formulations upon request. The Naloxegol Oxalate suppliers may include Naloxegol Oxalate API manufacturers, exporters, distributors and traders.
click here to find a list of Naloxegol Oxalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Naloxegol Oxalate DMF (Drug Master File) is a document detailing the whole manufacturing process of Naloxegol Oxalate active pharmaceutical ingredient (API) in detail. Different forms of Naloxegol Oxalate DMFs exist exist since differing nations have different regulations, such as Naloxegol Oxalate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Naloxegol Oxalate DMF submitted to regulatory agencies in the US is known as a USDMF. Naloxegol Oxalate USDMF includes data on Naloxegol Oxalate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Naloxegol Oxalate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Naloxegol Oxalate suppliers with USDMF on PharmaCompass.
A Naloxegol Oxalate written confirmation (Naloxegol Oxalate WC) is an official document issued by a regulatory agency to a Naloxegol Oxalate manufacturer, verifying that the manufacturing facility of a Naloxegol Oxalate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Naloxegol Oxalate APIs or Naloxegol Oxalate finished pharmaceutical products to another nation, regulatory agencies frequently require a Naloxegol Oxalate WC (written confirmation) as part of the regulatory process.
click here to find a list of Naloxegol Oxalate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Naloxegol Oxalate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Naloxegol Oxalate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Naloxegol Oxalate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Naloxegol Oxalate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Naloxegol Oxalate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Naloxegol Oxalate suppliers with NDC on PharmaCompass.
Naloxegol Oxalate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naloxegol Oxalate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naloxegol Oxalate GMP manufacturer or Naloxegol Oxalate GMP API supplier for your needs.
A Naloxegol Oxalate CoA (Certificate of Analysis) is a formal document that attests to Naloxegol Oxalate's compliance with Naloxegol Oxalate specifications and serves as a tool for batch-level quality control.
Naloxegol Oxalate CoA mostly includes findings from lab analyses of a specific batch. For each Naloxegol Oxalate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naloxegol Oxalate may be tested according to a variety of international standards, such as European Pharmacopoeia (Naloxegol Oxalate EP), Naloxegol Oxalate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naloxegol Oxalate USP).
LOOKING FOR A SUPPLIER?